何渡

::个人资料::

姓 名：何渡

性 别：男

学历学位：博士

职 称：副主任医师

职 务：肿瘤一科副主任

E-mail  ： 65637121@qq.com

研究方向：肿瘤的靶向治疗

单位：湖北民族大学附属恩施州中心医院

::个人简介：::

 何渡，男，肿瘤一科副主任，武汉大学人民医院肿瘤学博士研究生。先后到国内顶级的中山大学肿瘤医院及湖北省人民医院进修学习。主要方向为泌尿系统肿瘤、消化系统肿瘤及妇科肿瘤。率先在恩施州开展了宫颈癌的插植治疗及膀胱扫描仪在盆腔肿瘤中的应用的新技术。承担湖北省青年基金一项，参编医学著作5部，撰写医学论文近20余篇，其中SCI论文10余篇。任中国研究型医院精准医学与肿瘤MDT专业委员会青年委员，湖北省抗癌协会胃癌专业委员会委员，湖北省抗癌协会妇瘤专业委员会委员，湖北省抗癌协会靶向治疗专业委员会委员。

::目前承担的研究项目及经费：::

基于人工智能及组学技术建立多模态肝细胞癌的分子诊断及预后模型，湖北省卫生健康委科研项目（青年人才项目），2021/01-2022/12，8万(纵向经费)，项目主持人；

::科研成果及奖励：::

2016年获得湖北省优秀论文三等奖；

::公开发表论文及著作：::

[1] Ding Q, He D, He K, Zhang Q, Tang M, Dai J, Lv H, Wang X, Xiang G, Yu H. Downregulation of TRIM21 contributes to hepatocellular carcinoma carcinogenesis and indicates poor prognosis of cancers. Tumour Biol. 2015 Nov;36(11):8761-72.IF:3.611

[2] Wang Y, He D, Yang L, Wen B, Dai J, Zhang Q, Kang J, He W, Ding Q, He D. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis. Biochem Biophys Res Commun. 2015 Jul 31;463(3):458-65. IF:2.297

[3]He D, Hong L, Guo W. The role low microRNA-335 expression in prognosis prediction of human cancers. Journal of Cancer Research and Therapeutics. 2016 Sep 26;212(3):145-13. IF:1.326

[4] He D, Duan C, Chen J, Lai L, Chen J, Chen D. The safety and efficacy of the preoperative neoadjuvant chemotherapy for patients with cervical cancer: a systematic review and meta analysis. Int J Clin Exp Med. 2015 Sep 15;8(9):14693-700. IF:1.277

[5] Tu Z, He D, Deng X, Xiong M, Huang X, Li X, Hao L, Ding Q, Zhang Q. An eight-long non-coding RNA as a candidate prognostic biomarker for non-small cell lung cancer. Oncol Rep. 2016 Jul;36(1):215-22. IF:3.417

[6] Baowei Ji , Lihua Chen, Qiang Cai, Qiao Guo, Zhibiao Chen and Du He.Identification of an 8-miRNA signature as a potential prognostic biomarker for glioma.PeerJ.2020 Sep 28.10.7717. IF:3.5

[7] Du He, Xue Huang, Zai-Ping Wang, Dian Chen, Jun Chen and ChunYan Duan. Dietary fat intake and risk of esophageal carcinoma: a metaanalysis of observational studies.Oncotarget,2017,vol.8,(No.58),pp:99049-99056.7,IF: 5.168.Vol.

[8] Bing Wu, Li Teng, Du He, Dong-Dong Yu & Fan Jiang.Dose-response relation between serum total cholesterol levels and overall cancer risk: evidence

from 12 prospective studies involving 1,926,275 participants.Food Sciences and Nutrition. 2019, VOL. 70, NO. 4, 432–441.IF: 2.1.Vol.

[9]Qin L, Zhao T, Liu X, Wang H, Gu X, Chen D, Wang Z, He D.Malignant transformation arising from mature ovarian cystic teratoma: A case series.Medicine (Baltimore).2021 Apr 2;100(13).